-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.O3.6 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Optimizing Conditioning Regimens for Lymphoid Malignancies and Fanconi Anemia Clinically Relevant Abstract

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Lymphoid Leukemias, ALL, Biological therapies, Bone Marrow Failure Syndromes, Lymphomas, Diseases, Therapies, Lymphoid Malignancies, Transplantation
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
Moderators:
Andres Gomez-De Leon, MD, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González” and Roni Tamari, MD,
Disclosures:
Gomez-De Leon: Sanofi: Honoraria; Jnssen: Other: Advisory board; Astellas: Honoraria; Novartis: Honoraria; Abbvie: Honoraria; AMGEN: Honoraria.
This session presents novel approaches to conditioning regimens for patients with lymphoid malignancies and Fanconi Anemia undergoing allogeneic hematopoietic cell transplantation.
2:00 PM

Rajni Agarwal, MD1*, Alice Bertaina, MD, PhD2, Charmaine Fay Soco, PhD3*, Gopin Saini4*, Nivedita Kunte5*, Lyndsie Hiroshima, PharmD, BCPS, BCPPS6*, Yan Yi Chan5*, Hana Willner7*, Mark L. Krampf, MS7*, Rofida Nofal, MD5*, Giulia Barbarito, MS8*, Sushmita Sen7*, Matthias Felber, MD7*, Maite Van Hentenryck7*, Emily Walck7, Amelia Scheck4*, Supawat Thongthip4*, Aaron C. Logan, MD, PhD9, Kirstin Dougall, MBA7*, Ali Bouge7*, Jaap Jan Boelens, MD10, Janel R. Long-Boyle, PhD, PharmD11*, Irving L. Weissman, MD12, Judith Shizuru, MD, PhD13*, Wendy W Pang, MD, PhD5, Kenneth I. Weinberg, MD14*, Robertson Parkman, MD7, Maria-Grazia Roncarolo, MD15, Matthew Porteus, MD, PhD16 and Agnieszka Czechowicz, MD, PhD17,18,19

1Stanford Univ. School of Medicine, Palo Alto, CA
2Stanford University, Palo Alto, CA
32Dep artment of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
4Stanford University, Stanford, CA
5Stanford University School of Medicine, Stanford, CA
6Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, CA
7Stanford University School of Medicine, Stanford
8Stanford University School of Medicine, Palo Alto, CA
9Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
10Pediatr, MSKCC, New York, NY
11Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA
12Stanford University, School of Medicine, Stanford, CA
13Stanford U Med Ctr, Stanford, CA
14Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
15Stanford School of Medicine, Stanford, CA
16Department of Pediatrics, Stanford University, Stanford, CA
17Department of Pediatrics; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
18Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA
19Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA

2:15 PM

Caspian H. Oliai, MD1, Jeremy M. Pantin, MD2*, Rasmus T. Hoeg, MD3*, Lori S. Muffly, MD4, Sagar S. Patel, MD5, Arpita Gandhi, MD6, Robert Lowsky, MD7*, Amandeep Salhotra, MD8, Bhagirathbhai Dholaria, MBBS9, Edmund K. Waller, MD10, Samer A. Srour, MD11, Anna Pavlova, MD, PhD12, Nathaniel B. Fernhoff, PhD13*, Irene Agodoa, MD13, J. Scott McClellan, MD, PhD13, Mehrdad Abedi, MD14*, Robert S. Negrin, MD15 and Everett H. Meyer, MD, PhD16

1Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA
2Sarah Cannon Transplant and Cellular Therapy Program, Department of Hematopoietic Cell Therapy, TriStar Centennial Medical Center, Nashville, TN
3Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis, Sacramento, CA
4Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA
5Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
6Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
7Stanford Univ. Med. Ctr., Stanford, CA
8Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
9Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
10Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
11Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
12Orcabio, Menlo Park, CA
13Orca Bio, Menlo Park, CA
14Comprehensive Cancer Center, University of California, Davis, Sacramento, CA
15Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
16Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Medical Center, Stanford, CA

2:30 PM

Bertram Glass, MD, PhD1*, Bettina Altmann, PhD2*, Matthias Stelljes, MD3, Georg Lenz4, Julia Marx, MD4*, Justin Hasenkamp, MD5*, Frank P. Kroschinsky, MD, MBA6, Anna Ossami Saidy7*, Peter Dreger, MD8, Lutz Peter Hermann Mueller, MD, PhD9*, Inken Hilgendorf, MD10*, Gerald Illerhaus, MD11, Guido Kobbe, MD12*, Roland Schroers, MD13*, Katrin Linke14*, Carsta Koehler, PhD15*, Norbert Schmitz4*, Marita Ziepert, PhD2* and Pearl van Heteren, MD7*

1Klinik für Hämatologie und Zelltherapie, Helios Klinik Berlin-Buch, Berlin, Germany
2Institut für Medizinische Informatik, Statistik und Epidemiologie, Universität Leipzig, Leipzig, Germany
3University of Muenster, Muenster, Germany
4Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
5University Medicine Göttingen, Göttingen, DEU
6Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
7Helios Klinikum Berlin Buch, Berlin, Germany
8Universitätsklinikum, Heidelberg, DEU
9Department of Internal Medicine IV, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany
10Klinik für Innere Medizin II Abteilung für Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany
11Department of Hematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany
12Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
13Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Bochum, DEU
14GWT-TUD GmbH, Dresden, Germany
15GWT-TUD GmbH, Dresden, DEU

2:45 PM

Krzysztof Kalwak, MD, PhD1*, Peter Bader, MD, PhD2, Jean-Hugues Dalle3*, Petr Sedlacek, MD, PhD4*, Jochen Buechner, MD, PhD5*, Marianne Ifversen, MD6*, Peter Svec, MD, PhD7*, Jerry Stein, MD8*, Tayfun Güngör, MD9*, Jacek Toporski10*, Cristina Diaz De Heredia, MD11*, Marc Bierings, MD12, Roland Meisel, MD13*, Marc Ansari, MD, PhD14, Adriana Balduzzi15, Ulrike Poetschger16*, Dr. Peters17* and Franco Locatelli, MD, PhD18

1Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland
2University Children's Hospital Frankfurt, Frankfurt, DEU
3Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
4Department of Pediatric Hematology–Oncology, University Hospital Motol, Charles University, Prague, Czech Republic
5Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway
6Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
7Bone Marrow Transplantation Unit, Department of Pediatric Hematology and Oncology, National Institute of Children's Diseases, Comenius University, Bratislava, Slovakia
8Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel
9University Children's Hospital, Zürich, Switzerland, Zürich, Switzerland
10Tema Cancer, ME Cellterapi och Allogen Stamcellstransplantation (CAST) Internadress: M72-74 Karolinska Universitetssjukhuset, Huddinge, Stockholm, Sweden
11Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca, Barcelona, ESP
12-, Utrecht, NLD
13Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
14Hôpital Universitaire de Genève, Switzerland, Geneve, Switzerland
15Pediatric Hematopoietic Transplant Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy, School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy
16St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria
17St. Anna Children's Hospital, Vienna, AUT
18Department of Pediatrics, Catholic University of the Sacred Heart, Rome, Italy

3:00 PM

Issa F. Khouri, MD1, Kamal Alzahrani1*, Alison Gulbis2*, Koji Sasaki, MD3, Nitin Jain, MD3, Nicholas J. Short, MD3, Tapan M. Kadia, MD3, May Daher, MD4, Hind Rafei, MD1, Jin S Im1, David Marin, MD1, Amanda L. Olson, MD1, Uday R. Popat, MD1, Muzaffar H. Qazilbash, MD1, Jeremy Ramdial, MD1, Gabriela Rondon, MD1, Samer A. Srour, MD1, Partow Kebriaei, MD1, Elizabeth J. Shpall, MD1, Hagop M. Kantarjian, MD3, Richard E. Champlin, MD1 and Elias Jabbour5

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
5University of Texas M.D. Anderson Cancer Ctr., Houston, TX

3:15 PM

Hang Zhang, MD1*, Xinchuan Chen, MD, PhD2*, Tian Dong, MD, PhD3*, Pu Kuang, MD4*, Zhigang Liu, MD, PhD5*, Yu Wu, MD6, Yongqian Jia7*, Yun Tang, MD1*, Yang Dai, MD, PhD1*, Ting Niu, MD, PhD8, Ting Liu, MD1 and Jie Ji, MD, PhD9*

1Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China
2Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, CHN
3West China Hospital of Sichuan University, Chengdu, China, Chengdu, CHN
4West China Hospital, Sichuan University, Chengdu, CHN
5Department of Hematology, West China Hospital/State Key Laboratory of Biotherapy, Chengdu, CHN
6Department of Hematology and Hematology Research Laboratory, West China Hospital,Sichuan Universtiy, Chengdu, China
7West China Hospital, Sichuan University, Chengdu, China
8West China Hospital Sichuan University, Chengdu, Sichuan, China
9Department of Hematology and Institute of Hematology, Department of Hematology, West China Hospital of Sichuan University, Chengdu, China

*signifies non-member of ASH